BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

CUSIP: G11217125

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / *W EXP 12/02/202
Total 13F shares
9,397,302
Share change
+424,491
Total reported value
$1,334,588
Price per share
$0.15
Number of holders
45
Value change
+$62,736
Number of buys
7
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) as of Q2 2023

As of 30 Jun 2023, BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,397,302 shares. The largest 10 holders included Periscope Capital Inc., Saba Capital Management, L.P., Polar Asset Management Partners Inc., Linden Advisors LP, Calamos Advisors LLC, Shaolin Capital Management LLC, COWEN AND COMPANY, LLC, GOLDMAN SACHS GROUP INC, MMCAP International Inc. SPC, and AQR Arbitrage LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.